RNA-Anchoring Fluorescent Probe for Long-Window Tumor Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing materials for tumor imaging and treatment fail to accumulate in tumor tissues for a long time, reducing their bioavailability and efficacy.

Innovation Solution

A novel red-light-mediated nucleic acid anchoring fluorescent probe is synthesized through specific chemical reactions, enabling prolonged in vivo fluorescence and photoacoustic imaging by cross-linking with RNA in tumor cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If existing materials are used for tumor imaging and treatment, then the materials can be introduced into tumor tissues, but they cannot accumulate in tumor tissues for a long time, reducing bioavailability

Engineering Contradiction:
Improveaccumulation time in tumor tissuesVSAvoidbioavailability
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The probe is designed with a nucleic acid anchoring group that performs preliminary binding to RNA in tumor cells before the therapeutic or imaging function is activated. This preliminary anchoring action ensures long-term retention and accumulation in tumor tissues, solving the problem of short residence time of existing materials.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The probe uses RNA as an intermediary molecule to mediate the accumulation and retention of the fluorescent probe in tumor tissues. By anchoring to RNA, the probe achieves long-term accumulation without being rapidly cleared, thereby improving both accumulation time and bioavailability.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of stationary object

If the probe accumulates in tumor tissues for a long time, then bioavailability is improved, but the complexity of the probe structure increases

Engineering Contradiction:
Improveretention time in tumor tissuesVSAvoidprobe structure complexity
Core Design Contradiction:
Duration of action of stationary objectVSDevice complexity

Solution Approach 1:

The probe merges multiple functions into a single molecular structure: fluorescence emission for imaging, photoacoustic conversion for thermal/photothermal therapy, and nucleic acid anchoring for long-term retention. This consolidation achieves long retention time while managing structural complexity through functional integration rather than separate components.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The probe is designed with multi-functionality, serving as an imaging agent, a therapy agent, and an accumulation agent simultaneously. The universal design allows a single probe molecule to achieve long-term retention in tumor tissues without requiring multiple separate materials, thus balancing retention time with structural complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If the probe uses cross-linking ability to anchor in tumor cells, then imaging and therapy efficacy is improved, but the chemical reaction complexity increases

Engineering Contradiction:
Improveimaging and therapy efficacyVSAvoidchemical reaction complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The probe employs self-service cross-linking chemistry where the probe molecule automatically anchors to RNA in tumor cells through its inherent nucleic acid anchoring group. This self-anchoring mechanism improves imaging and therapy efficacy without requiring external cross-linking agents or complex chemical reactions, thus maintaining chemical simplicity.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The probe utilizes parameter changes in the chemical environment of tumor cells (such as pH, ionic strength, or RNA concentration) to trigger the cross-linking or anchoring reaction. This allows the probe to activate its cross-linking ability selectively in tumor cells under physiological conditions, improving efficacy while avoiding complex controlled chemical reactions.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The probe achieves long-term retention in tumor tissues, promotes apoptosis of tumor cells, and inhibits tumor growth through cross-linking with RNA, enhancing imaging time and therapeutic efficacy.

Implementation Method 1

utilizes the advantages of its groups of cross-linking ability... to carry out longstanding in vivo fluorescence

Methodology Applied
Scientific EffectChemical bonding: Chemical Bonding

Implementation Method 2

near-infrared emission to carry out longstanding in vivo fluorescence

Methodology Applied
Scientific EffectPhotoluminescence: Photoluminescence

Implementation Method 3

photoacoustic imaging

Methodology Applied
Scientific EffectPhotoacoustic effect: Photoacoustic Effect

Data Source

PatentUS12480043B2Red-light-mediated nucleic acid anchoring-type fluorescent probe, and preparation method therefor and use thereof
Publication Date: 2025.11.25 SUZHOU UNIV
  • US12480043B2 patent drawing
  • US12480043B2 patent drawing
  • US12480043B2 patent drawing

AI summary

The present invention disclosed a red-light-mediated nucleic acid anchoring fluorescent probe and its preparation method and application. The fluorescent probe has the capability of taking a crosslinking reaction with RNA in cytoplasm under singlet oxygen mediation, and imaging of tumor tissues in a long window period is achieved. Moreover, it is found that by means of the probe, after crosslinking of RNA, a severe apoptosis phenomenon of tumor cells occurs, and the integration of diagnosis and treatment of tumors is achieved.